Radiation therapy in extrahepatic bile duct carcinoma

Area of Science:

• Oncology
• Radiation Oncology
• Surgical Oncology

Background:

• Extrahepatic bile duct (EHBD) carcinoma is a rare and aggressive malignancy.
• Treatment outcomes for EHBD carcinoma are often poor, necessitating investigation into effective therapeutic strategies.

Purpose of the Study:

• To evaluate the efficacy of radiation therapy in patients with extrahepatic bile duct carcinoma.
• To compare survival outcomes based on treatment intent (curative vs. palliative) and surgical resection status.

Main Methods:

• Retrospective analysis of 51 patients with EHBD carcinoma treated with radiation therapy between 1980 and 1988.
• Treatment modalities included external radiation therapy (ERT), iridium-192 (192Ir) brachytherapy, or a combination.
• Patients were categorized by tumor location, surgical resection status (complete, incomplete, biopsy only), and treatment intent.

Main Results:

• Overall median survival was 12 months. Patients treated with curative intent had a median survival of 22 months, compared to 10 months for palliative treatment (p=0.03).
• Among patients receiving curative treatment, median survival was 27.5 months after complete gross resection versus 13 months after incomplete resection (p=0.045).
• Tumor location and specific radiation techniques (ERT, 192Ir, or combined) were detailed, with varying dose regimens for curative and palliative intent.

Conclusions:

• Radiation therapy, particularly when combined with complete surgical resection and administered with curative intent, can improve survival outcomes in patients with EHBD carcinoma.
• Incomplete resection and palliative treatment strategies are associated with significantly poorer prognoses.